MedTrace Logo

Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure

NCT02865785 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2016-08-12

No results posted yet for this study

Summary

The aim of present study is to evaluate the effect of intralipid 20% infusion, once between days 4 and 9 of the ovarian stimulation, and again within 7 days of a positive pregnancy test on clinical pregnancy rates in women with unexplained recurrent implantation failure.

Conditions

  • Subfertility

Interventions

DRUG

Intralipid 20%

intralipid D4-9 of induction ovulation to be repeated within 7 days of positive pregnancy test.

DRUG

Placebo

saline infusion D4-9 of induction of ovulation to be repeated within 7 days of positive pregnancy test.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Khaled Afifi, MBBCH · Resident of O&G

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2017-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02865785 on ClinicalTrials.gov